Haplotypes of FcgRIIa and FcgRIIIb polymorphic variants influence IgG-mediated responses in neutrophils

Journal of Immunology

Volumn 192, Issue 6, 2014, Pages 2715-2721

  Van Der Heijden, Joris ^a   Nagelkerke, Sietse ^a   Zhao, Xiwen ^a   Geissler, Judy ^a   Rispens, Theo ^a   Van Den Berg, Timo K ^a   Kuijpers, Taco W ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; FC GAMMA RECEPTOR IIIB; FC RECEPTOR IIA; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG; FC RECEPTOR; FCGR3B PROTEIN, HUMAN; GAMMA INTERFERON; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROGEN PEROXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADULT; ANTIBODY RESPONSE; ARTICLE; BINDING AFFINITY; CAUCASIAN; CELL ACTIVATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; CELL CULTURE; DRUG EFFECT; FLOW CYTOMETRY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; METABOLISM;

CELLS, CULTURED; FLOW CYTOMETRY; GENE FREQUENCY; GENOTYPE; GPI-LINKED PROTEINS; GRANULOCYTE COLONY-STIMULATING FACTOR; HAPLOTYPES; HUMANS; HYDROGEN PEROXIDE; IMMUNOGLOBULIN G; INTERFERON-GAMMA; NADPH OXIDASE; NEUTROPHILS; POLYMORPHISM, GENETIC; RECEPTORS, IGG;

EID: 84897534331     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203570     Document Type: Article

References (36)

1. Warmerdam, P. A., J. G. van de Winkel, E. J. Gosselin, and P. J. Capel. 1990. Molecular basis for a polymorphism of human Fcγ receptor II (CD32). J. Exp. Med. 172: 19-25.
2. Li, X., J. Wu, R. H. Carter, J. C. Edberg, K. Su, G. S. Cooper, and R. P. Kimberly. 2003. A novel polymorphism in the Fcγ receptor IIB (CD32B) transmembrane region alters receptor signaling. Arthritis Rheum. 48: 3242-3252.
3. Metes, D., L. K. Ernst, W. H. Chambers, A. Sulica, R. B. Herberman, and P. A. Morel. 1998. Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcγRIIC gene. Blood 91: 2369-2380.
4. Wu, J., J. C. Edberg, P. B. Redecha, V. Bansal, P. M. Guyre, K. Coleman, J. E. Salmon, and R. P. Kimberly. 1997. A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J. Clin. Invest. 100: 1059-1070.
5. Ory, P. A., M. R. Clark, E. E. Kwoh, S. B. Clarkson, and I. M. Goldstein. 1989. Sequences of complementary DNAs that encode the NA1 and NA2 forms of Fc receptor III on human neutrophils. J. Clin. Invest. 84: 1688-1691.
6. Bux, J., E. L. Stein, P. Bierling, P. Fromont, M. Clay, D. Stroncek, and S. Santoso. 1997. Characterization of a new alloantigen (SH) on the human neutrophil Fcg receptor IIIb. Blood 89: 1027-1034.
7. Breunis, W. B., E. van Mirre, J. Geissler, N. Laddach, G. Wolbink, E. van der Schoot, M. de Haas, M. de Boer, D. Roos, and T. W. Kuijpers. 2009. Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B. Hum. Mutat. 30: E640-E650.
8. Breunis, W. B., E. van Mirre, M. Bruin, J. Geissler, M. de Boer, M. Peters, D. Roos, M. de Haas, H. R. Koene, and T. W. Kuijpers. 2008. Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura. Blood 111: 1029-1038.
9. van der Heijden, J., W. B. Breunis, J. Geissler, M. de Boer, T. K. van den Berg, and T. W. Kuijpers. 2012. Phenotypic variation in IgG receptors by nonclassical FCGR2C alleles. J. Immunol. 188: 1318-1324.
10. Bruhns, P., B. Iannascoli, P. England, D. A. Mancardi, N. Fernandez, S. Jorieux, and M. Daëron. 2009. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 113: 3716-3725.
11. Nicu, E. A., U. Van der Velden, V. Everts, A. J. Van Winkelhoff, D. Roos, and B. G. Loos. 2007. Hyper-reactive PMNs in FcγRIIa 131 H/H genotype periodontitis patients. J. Clin. Periodontol. 34: 938-945.
12. Bredius, R. G., C. A. Fijen, M. De Haas, E. J. Kuijper, R. S. Weening, J. G. Van de Winkel, and T. A. Out. 1994. Role of neutrophil FcγRIIa (CD32) and FcgRIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes. Immunology 83: 624-630.
13. Salmon, J. E., J. C. Edberg, and R. P. Kimberly. 1990. Fcg receptor III on human neutrophils. Allelic variants have functionally distinct capacities. J. Clin. Invest. 85: 1287-1295.
14. van Sorge, N. M., W. L. van der Pol, and J. G. van de Winkel. 2003. FcgR polymorphisms: Implications for function, disease susceptibility and immunotherapy. Tissue Antigens 61: 189-202.
15. Veri, M. C., S. Gorlatov, H. Li, S. Burke, S. Johnson, J. Stavenhagen, K. E. Stein, E. Bonvini, and S. Koenig. 2007. Monoclonal antibodies capable of discriminating the human inhibitory Fcg-receptor IIB (CD32B) from the activating Fcgreceptor IIA (CD32A): biochemical, biological and functional characterization. Immunology 121: 392-404.
16. Schouten, J. P., C. J. McElgunn, R. Waaijer, D. Zwijnenburg, F. Diepvens, and G. Pals. 2002. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 30: e57.
17. van Bruggen, R., A. Drewniak, M. Jansen, M. van Houdt, D. Roos, H. Chapel, A. J. Verhoeven, and T. W. Kuijpers. 2009. Complement receptor 3, not Dectin-1, is the major receptor on human neutrophils for b-glucan-bearing particles. Mol. Immunol. 47: 575-581.
18. Kurlander, R. J. 1983. Blockade of Fc receptor-mediated binding to U-937 cells by murine monoclonal antibodies directed against a variety of surface antigens. J. Immunol. 131: 140-147.
19. Lehrnbecher, T., C. B. Foster, S. Zhu, S. F. Leitman, L. R. Goldin, K. Huppi, and S. J. Chanock. 1999. Variant genotypes of the low-affinity Fcγ receptors in two control populations and a review of low-affinity Fcg receptor polymorphisms in control and disease populations. Blood 94: 4220-4232.
20. Repp, R., T. Valerius, A. Sendler, M. Gramatzki, H. Iro, J. R. Kalden, and E. Platzer. 1991. Neutrophils express the high affinity receptor for IgG (FcgRI, CD64) after in vivo application of recombinant human granulocyte colonystimulating factor. Blood 78: 885-889.
21. Perussia, B., E. T. Dayton, R. Lazarus, V. Fanning, and G. Trinchieri. 1983. Immune interferon induces the receptor for monomeric IgG1 on human monocytic and myeloid cells. J. Exp. Med. 158: 1092-1113.
22. Fossati, G., R. J. Moots, R. C. Bucknall, and S. W. Edwards. 2002. Differential role of neutrophil Fcg receptor IIIB (CD16) in phagocytosis, bacterial killing, and responses to immune complexes. Arthritis Rheum. 46: 1351-1361.
23. Cohen, D. M., S. C. Bhalla, E. J. Anaissie, J. P. Hester, C. A. Savary, and J. H. Rex. 1997. Effects of in vitro and in vivo cytokine treatment, leucapheresis and irradiation on the function of human neutrophils: implications for white blood cell transfusion therapy. Clin. Lab. Haematol. 19: 39-47.
24. Gericke, G. H., S. G. Ericson, L. Pan, L. E. Mills, P. M. Guyre, and P. Ely. 1995. Mature polymorphonuclear leukocytes express high-affinity receptors for IγG (FcγRI) after stimulation with granulocyte colony-stimulating factor (G-CSF). J. Leukoc. Biol. 57: 455-461.
25. Homburg, C. H., M. de Haas, A. E. von dem Borne, A. J. Verhoeven, C. P. Reutelingsperger, and D. Roos. 1995. Human neutrophils lose their surface FcγRIII and acquire annexin V binding sites during apoptosis in vitro. Blood 85: 532-540.
26. Su, K., J. Wu, J. C. Edberg, X. Li, P. Ferguson, G. S. Cooper, C. D. Langefeld, and R. P. Kimberly. 2004. A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcγRIIb alters receptor expression and associates with autoimmunity. I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus. J. Immunol. 172: 7186-7191.
27. Su, K., X. Li, J. C. Edberg, J. Wu, P. Ferguson, and R. P. Kimberly. 2004. A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motifbearing FcγRIIb alters receptor expression and associates with autoimmunity. II. Differential binding of GATA4 and Yin-Yang1 transcription factors and correlated receptor expression and function. J. Immunol. 172: 7192-7199.
28. Floto, R. A., M. R. Clatworthy, K. R. Heilbronn, D. R. Rosner, P. A. MacAry, A. Rankin, P. J. Lehner, W. H. Ouwehand, J. M. Allen, N. A. Watkins, and K. G. Smith. 2005. Loss of function of a lupus-associated FcγRIIb polymorphism through exclusion from lipid rafts. Nat. Med. 11: 1056-1058.
29. Nimmerjahn, F., and J. V. Ravetch. 2008. Fcg receptors as regulators of immune responses. Nat. Rev. Immunol. 8: 34-47.
30. Crockett-Torabi, E., and J. C. Fantone. 1990. Soluble and insoluble immune complexes activate human neutrophil NADPH oxidase by distinct Fcγ receptorspecific mechanisms. J. Immunol. 145: 3026-3032.
31. Huang, Z. Y., S. Hunter, P. Chien, M. K. Kim, T. H. Han-Kim, Z. K. Indik, and A. D. Schreiber. 2011. Interaction of two phagocytic host defense systems: Fcγ receptors and complement receptor 3. J. Biol. Chem. 286: 160-168.
32. Marzocchi-Machado, C. M., C. M. Alves, A. E. Azzolini, A. C. Polizello, I. F. Carvalho, and Y. M. Lucisano-Valim. 2002. Fcgamma and complement receptors: expression, role and co-operation in mediating the oxidative burst and degranulation of neutrophils of Brazilian systemic lupus erythematosus patients. Lupus 11: 240-248.
33. Voice, J. K., and P. J. Lachmann. 1997. Neutrophil Fcg and complement receptors involved in binding soluble IgG immune complexes and in specific granule release induced by soluble IgG immune complexes. Eur. J. Immunol. 27: 2514-2523.
34. Zhou, M., R. F. Todd, III, J. G. van de Winkel, and H. R. Petty. 1993. Cocapping of the leukoadhesin molecules complement receptor type 3 and lymphocyte function-associated antigen-1 with Fcγ receptor III on human neutrophils. Possible role of lectin-like interactions. J. Immunol. 150: 3030-3041.
35. Dougherty, G. J., Y. Selvendran, S. Murdoch, D. G. Palmer, and N. Hogg. 1987. The human mononuclear phagocyte high-affinity Fc receptor, FcRI, defined by a monoclonal antibody, 10.1. Eur. J. Immunol. 17: 1453-1459.
36. Bournazos, S., J. M. Woof, S. P. Hart, and I. Dransfield. 2009. Functional and clinical consequences of Fc receptor polymorphic and copy number variants. Clin. Exp. Immunol. 157: 244-254.